top of page

CHO-K1/Human QRFP Stable Cell

Item
Cat#
Price

Stable Cell Line

SNB-G-0207A

$19,800

Compound Testing Services

CT-001

$1,850 per 384w plate

(Up To 16 cpds Dose)


Product Description


The QRFP receptor, also known as GPR103, is a G protein-coupled receptor primarily expressed in the central nervous system (e.g., hypothalamus, amygdala, hippocampus) and peripheral tissues (e.g., retina, heart, kidney, and testis). Upon activation by its ligand QRFP (an RF-amide neuropeptide), it mediates intracellular calcium mobilization and cAMP modulation via Gq and Gi/o proteins, playing key roles in regulating feeding behavior and energy homeostasis, modulating blood pressure and heart rate, influencing bone formation, and participating in nociception. This receptor has emerged as a potential drug target for obesity, metabolic syndrome, and cardiovascular diseases.

 

Screeningbio’s CHO-K1/Human QRFP cell line overexpress QRFPR receptor and is designed to detect increases in intracellular IP-1 levels in response to agonist stimulation of the receptor. Cisbio HTRF IP-1 kit can be used to detect the signal.

Product Specifications

Target Type

GPCR

Species

Human

HGNC Symbol

QRFPR

Accession Number

NM_198179 (Hs)

Parental Line

CHO-K1

Lot#

See Vial

Storage

Liquid Nitrogen


Data

CHO-K1/Human QRFP Agonist Assay. CHO-K1/Human QRFP cells were treated with the reference agonist. The assay was run based on Revvity IP-one HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 /IC50 values were determined, using GraphPad Prism software.
CHO-K1/Human QRFP Agonist Assay. CHO-K1/Human QRFP cells were treated with the reference agonist. The assay was run based on Revvity IP-one HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 /IC50 values were determined, using GraphPad Prism software.


Target Background


The QRFP receptor, also known as GPR103, is a G protein-coupled receptor primarily expressed in the central nervous system (e.g., hypothalamus, amygdala, hippocampus) and peripheral tissues (e.g., retina, heart, kidney, and testis).


Upon activation by its ligand QRFP (an RF-amide neuropeptide), it mediates intracellular calcium mobilization and cAMP modulation via Gq and Gi/o proteins, playing key roles in regulating feeding behavior and energy homeostasis, modulating blood pressure and heart rate, influencing bone formation, and participating in nociception.


This receptor has emerged as a potential drug target for obesity, metabolic syndrome, and cardiovascular diseases.

Product Documentation



bottom of page